Proteomic genotyping of SNP of Complement Factor H (CFH) Y402H and I62V using multiple reaction monitoring (MRM) assays

Abstract The single nucleotide polymorphisms (SNPs) of complement factor H (CFH) gene are well-known genetic risk factors for age-related macular degeneration (AMD). To identify whether the measurement of plasma protein concentrations of CFH variants using the multiple reaction monitoring (MRM) assa...

Full description

Bibliographic Details
Main Authors: Kyoung Lae Kim, Hyerim Kim, Youngju Lee, Cheolju Lee, Kwangsic Joo, Sang Jun Park, Kyu Hyung Park, Seong-Jun Park, Se Joon Woo
Format: Article
Language:English
Published: Nature Portfolio 2022-11-01
Series:Scientific Reports
Online Access:https://doi.org/10.1038/s41598-022-20936-8
_version_ 1798016897053097984
author Kyoung Lae Kim
Hyerim Kim
Youngju Lee
Cheolju Lee
Kwangsic Joo
Sang Jun Park
Kyu Hyung Park
Seong-Jun Park
Se Joon Woo
author_facet Kyoung Lae Kim
Hyerim Kim
Youngju Lee
Cheolju Lee
Kwangsic Joo
Sang Jun Park
Kyu Hyung Park
Seong-Jun Park
Se Joon Woo
author_sort Kyoung Lae Kim
collection DOAJ
description Abstract The single nucleotide polymorphisms (SNPs) of complement factor H (CFH) gene are well-known genetic risk factors for age-related macular degeneration (AMD). To identify whether the measurement of plasma protein concentrations of CFH variants using the multiple reaction monitoring (MRM) assay can determine the genotypes of CFH SNP rs1061170 and rs800292, 120 patients with AMD and 26 controls were included in this study. The number of cases were TT:TC:CC = 121:24:1 in CFH SNP Y402H and GG:AG:AA = 72:57:17 in CFH SNP I62V. Plasma concentrations of tryptic peptides were measured using the MRM assay, and tyrosine/histidine (Y/H) and valine/isoleucine (V/I) CFH variant protein ratios were obtained. To discriminate the genotypes by the plasma protein ratios, cut-off values were set for Y/H ratios (TT: > 4.428; TC: 1.00–4.428; CC: < 1.00) and V/I ratios (GG: > 1.09; AG: 0.0089–1.08; AA: < 0.0089). Correlation analysis revealed that the plasma CFH variant protein ratios and genotypes of CFH were exactly matched (100%) without overlap in the total patients and controls. The measurement of plasma protein CFH variants using the MRM assay can accurately identify the genotypes of CFH SNPs of Y402H and I62V.
first_indexed 2024-04-11T15:56:49Z
format Article
id doaj.art-6eca0d860cac4fbba90642f57728b0cb
institution Directory Open Access Journal
issn 2045-2322
language English
last_indexed 2024-04-11T15:56:49Z
publishDate 2022-11-01
publisher Nature Portfolio
record_format Article
series Scientific Reports
spelling doaj.art-6eca0d860cac4fbba90642f57728b0cb2022-12-22T04:15:07ZengNature PortfolioScientific Reports2045-23222022-11-011211910.1038/s41598-022-20936-8Proteomic genotyping of SNP of Complement Factor H (CFH) Y402H and I62V using multiple reaction monitoring (MRM) assaysKyoung Lae Kim0Hyerim Kim1Youngju Lee2Cheolju Lee3Kwangsic Joo4Sang Jun Park5Kyu Hyung Park6Seong-Jun Park7Se Joon Woo8Department of Ophthalmology, Seoul National University College of Medicine, Seoul National University Bundang HospitalDepartment of Research, RetiMark Co., LtdDepartment of Research, RetiMark Co., LtdCenter for Theragnosis, Korea Institute of Science and TechnologyDepartment of Ophthalmology, Seoul National University College of Medicine, Seoul National University Bundang HospitalDepartment of Ophthalmology, Seoul National University College of Medicine, Seoul National University Bundang HospitalDepartment of Ophthalmology, Seoul National University College of Medicine, Seoul National University Bundang HospitalDepartment of Research, RetiMark Co., LtdDepartment of Ophthalmology, Seoul National University College of Medicine, Seoul National University Bundang HospitalAbstract The single nucleotide polymorphisms (SNPs) of complement factor H (CFH) gene are well-known genetic risk factors for age-related macular degeneration (AMD). To identify whether the measurement of plasma protein concentrations of CFH variants using the multiple reaction monitoring (MRM) assay can determine the genotypes of CFH SNP rs1061170 and rs800292, 120 patients with AMD and 26 controls were included in this study. The number of cases were TT:TC:CC = 121:24:1 in CFH SNP Y402H and GG:AG:AA = 72:57:17 in CFH SNP I62V. Plasma concentrations of tryptic peptides were measured using the MRM assay, and tyrosine/histidine (Y/H) and valine/isoleucine (V/I) CFH variant protein ratios were obtained. To discriminate the genotypes by the plasma protein ratios, cut-off values were set for Y/H ratios (TT: > 4.428; TC: 1.00–4.428; CC: < 1.00) and V/I ratios (GG: > 1.09; AG: 0.0089–1.08; AA: < 0.0089). Correlation analysis revealed that the plasma CFH variant protein ratios and genotypes of CFH were exactly matched (100%) without overlap in the total patients and controls. The measurement of plasma protein CFH variants using the MRM assay can accurately identify the genotypes of CFH SNPs of Y402H and I62V.https://doi.org/10.1038/s41598-022-20936-8
spellingShingle Kyoung Lae Kim
Hyerim Kim
Youngju Lee
Cheolju Lee
Kwangsic Joo
Sang Jun Park
Kyu Hyung Park
Seong-Jun Park
Se Joon Woo
Proteomic genotyping of SNP of Complement Factor H (CFH) Y402H and I62V using multiple reaction monitoring (MRM) assays
Scientific Reports
title Proteomic genotyping of SNP of Complement Factor H (CFH) Y402H and I62V using multiple reaction monitoring (MRM) assays
title_full Proteomic genotyping of SNP of Complement Factor H (CFH) Y402H and I62V using multiple reaction monitoring (MRM) assays
title_fullStr Proteomic genotyping of SNP of Complement Factor H (CFH) Y402H and I62V using multiple reaction monitoring (MRM) assays
title_full_unstemmed Proteomic genotyping of SNP of Complement Factor H (CFH) Y402H and I62V using multiple reaction monitoring (MRM) assays
title_short Proteomic genotyping of SNP of Complement Factor H (CFH) Y402H and I62V using multiple reaction monitoring (MRM) assays
title_sort proteomic genotyping of snp of complement factor h cfh y402h and i62v using multiple reaction monitoring mrm assays
url https://doi.org/10.1038/s41598-022-20936-8
work_keys_str_mv AT kyounglaekim proteomicgenotypingofsnpofcomplementfactorhcfhy402handi62vusingmultiplereactionmonitoringmrmassays
AT hyerimkim proteomicgenotypingofsnpofcomplementfactorhcfhy402handi62vusingmultiplereactionmonitoringmrmassays
AT youngjulee proteomicgenotypingofsnpofcomplementfactorhcfhy402handi62vusingmultiplereactionmonitoringmrmassays
AT cheoljulee proteomicgenotypingofsnpofcomplementfactorhcfhy402handi62vusingmultiplereactionmonitoringmrmassays
AT kwangsicjoo proteomicgenotypingofsnpofcomplementfactorhcfhy402handi62vusingmultiplereactionmonitoringmrmassays
AT sangjunpark proteomicgenotypingofsnpofcomplementfactorhcfhy402handi62vusingmultiplereactionmonitoringmrmassays
AT kyuhyungpark proteomicgenotypingofsnpofcomplementfactorhcfhy402handi62vusingmultiplereactionmonitoringmrmassays
AT seongjunpark proteomicgenotypingofsnpofcomplementfactorhcfhy402handi62vusingmultiplereactionmonitoringmrmassays
AT sejoonwoo proteomicgenotypingofsnpofcomplementfactorhcfhy402handi62vusingmultiplereactionmonitoringmrmassays